GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

User:Vtran1

From GONUTS
Jump to: navigation, search

My Annotations

StatusPageDate/TimeGO Term (Aspect)ReferenceEvidenceNotesLinks
requireschangesHAEDU:HGBA2012-09-23 17:25:21 CDTGO:0030492 hemoglobin binding (F)PMID:7890379ECO:0000314 direct assay evidence used in manual assertion

Fig 1 shows SDS-page gel of HgbA from solubilized outer membranes of H. ducreyi strain 35000 affinity purified on human hemoglobin.

challenge
acceptableHAEDC:Q9K2H62012-09-23 17:32:09 CDTGO:0009279 cell outer membrane (C)PMID:10678980ECO:0000314 direct assay evidence used in manual assertion

Fig 5 shows the SDS-PAGE and Western blot identifying DsrA. Figure caption includes details about preparation of outer membrane for experiment.

challenge
acceptableHAEDC:F6KZW92012-10-16 19:13:12 CDTGO:0030682 evasion or tolerance of host defense response (P)PMID:21444663ECO:0000315 mutant phenotype evidence used in manual assertion

Figures 5 and 6 show the effect of mtrC deletion on resistance to the mammalian defenses LL-37 and beta defensin. The plasmid-complemented mutant was not significantly different from the parent.

challenge
acceptableHAEDC:F6KZW92012-10-16 13:47:10 CDTGO:0010628 positive regulation of gene expression (P)PMID:21444663ECO:0000315 mutant phenotype evidence used in manual assertion

Figure 4 shows the effect of mtrC deletion on mRNA levels of four CpxRA-regulated genes. The genes fimA and omp2B are known to be upregulated by CpxRA, while lspB and dsrA are downregulated by activation of the CpxRA regulation system. These results, combined with the information in Figure 3C, led the authors to conclude that the CpxRA system was activated in the mtrC deletion mutant.

challenge
acceptableAGGAC:Q7DK122012-10-16 19:12:13 CDTGO:0044072 negative regulation by symbiont of host cell cycle (P)PMID:10946289ECO:0000315 mutant phenotype evidence used in manual assertion

Figures 4 and 5 show the effect of targeted modifications of cdt genes on immunoinhibition. Human T cells were incubated with proteins produced from the cdt mutant-carrying plasmids (schematic in figure 3), and the cell cycle distribution was analyzed. Of particular interest are Figures 5bc, which demonstrate the high levels of G2 arrest in the cdtB mutant.

challenge
requireschangesHAEDU:CDTA2012-10-16 18:13:18 CDTGO:0001907 killing by symbiont of host cells (P)PMID:11453636ECO:0000314 direct assay evidence used in manual assertion

Figure 2D shows that the eluate of a cdtA mutant strain is not detectably cytotoxic. Cytotoxicity can be restored by mixture of CdtB and CdtC with the sonicated cell lysate of E. coli expressing cdtA. This recovery was not seen upon combination of CdtB and CdtC alone or with the sonicated cell lysate of E.coli carrying a control plasmid (Figure 4, especially 4G vs 4FH).

challenge
acceptableHAEDC:Q67BF62012-10-17 19:06:32 CDTGO:0009405 pathogenesis (P)PMID:16428791ECO:0000315 mutant phenotype evidence used in manual assertion

Table 1 shows the effect of inoculation of human volunteers with H. ducreyi. Subjects were infected with the wild-type on one arm and the DltA mutant on the other. The mutant had decreased papule formation, demonstrating that DltA plays a role in pathogenesis.

challenge
requireschangesHAEDU:G1UBA52012-10-17 21:16:17 CDTGO:0009279 cell outer membrane (C)PMID:11401984ECO:0000315 mutant phenotype evidence used in manual assertion

Fig 3 shows the SDS-PAGE and Western blot identifying D15. Figure caption includes details about preparation of outer membrane for experiment. Figure 2 shows comparison of the amino acid sequence to other D15 proteins.

challenge
requireschangesHAEDC:Q9ZHL32012-10-17 20:31:08 CDTGO:0020012 evasion or tolerance of host immune response (P)PMID:14500520ECO:0000315 mutant phenotype evidence used in manual assertion

Figures 1 and 2 show the ability of the LspA1 mutant to inhibit the phagocytic activity of HL-60 and U-937, respectively. The LspA1 mutant, shown in column 3, is very like the wild type (column 1).

challenge
requireschangesHAEDC:Q9ZHL02012-10-17 20:31:30 CDTGO:0052200 response to host defenses (P)PMID:14500520ECO:0000315 mutant phenotype evidence used in manual assertion

Figures 1 and 2 show the ability of the LspA2 mutant to inhibit the phagocytic activity of HL-60 and U-937, respectively. The LspA2 mutant, shown in column 4, is very like the wild type (column 1).

challenge
acceptableHAEDU:Q7VLH62012-10-17 21:52:21 CDTGO:0010629 negative regulation of gene expression (P)PMID:19451237ECO:0000315 mutant phenotype evidence used in manual assertion

Figure 5 shows increased expression of LspA2, LspA1, and LspB in CpxR mutants (lane 2 vs lane 2) and decreased expression in complemented mutants (lane 3 vs lane 4), indicating negative regulation of these genes by CpxR.

challenge
acceptableHAEDU:Q7VM012012-10-18 10:54:45 CDTGO:0030682 evasion or tolerance of host defense response (P)PMID:20086092ECO:0000315 mutant phenotype evidence used in manual assertion

Figure 3 shows the effect of sapA mutation on resistance to the mammalian defense LL-37. The plasmid-complemented mutant was not significantly different from the parent. No resistance was seen for alpha- and beta- defensins.

challenge
acceptableHAEDC:Q9K2H62012-10-18 14:09:29 CDTGO:0009405 pathogenesis (P)PMID:11179317ECO:0000315 mutant phenotype evidence used in manual assertion

Tables 1 and 2 show the results of inoculation with wild-type and DsrA mutant H. ducreyi. Table 1 shows that the mutant is impaired in its ability to cause papules. Table 2 shows that the mutant (at an increased dose) forms smaller papules than the wild-type, on par with the heat-inactivated wild-type.

challenge
acceptableHAEDC:Q9K2H62012-10-18 14:33:44 CDTGO:0020012 evasion or tolerance of host immune response (P)PMID:10678980ECO:0000315 mutant phenotype evidence used in manual assertion

Figure 6 shows that the DsrA mutant has lower resistance to bactericidal killing than the wild-type organism. Figure 7 shows that complementation of the mutant restores resistance

challenge
acceptableHAEDC:Q58ZK42012-10-18 16:20:09 CDTGO:0009279 cell outer membrane (C)PMID:16622201ECO:0000314 direct assay evidence used in manual assertion

The materials and methods section entitled "Radioimmunoprecipitation of H. ducreyi outer membrane proteins" describes the process used to isolate the outer membrane proteins.

challenge
acceptableHAEDC:Q58ZK42012-10-18 16:20:09 CDTGO:0009405 pathogenesis (P)PMID:16622201ECO:0000315 mutant phenotype evidence used in manual assertion

Tables 1 and 2 show the results of inoculation of wild-type and ncaA mutant H. ducreyi. The mutant had decreased virulence in the swine (table 1) and human (table 2) models of infection compared to the wild-type.

challenge

acceptable:11
unacceptable:0
requires_changes:5
flagged:0

Annotations challenged by Vtran1

StatusAuthor,GroupPageGO Term (Aspect)ReferenceEvidenceLinksPage history
requireschangesCourtney.kast,
Team Team
XENLA:SHRM3GO:0048546 - digestive tract morphogenesis (P)PMID:20332151ECO:0000314 direct assay evidence used in manual assertionchallengeC: 2
updatedbyinstructorKatelin.Aisenbrey,
Team Gene Wilder
HUMAN:DNLI1GO:0003909 - DNA ligase activity (F)PMID:15871698ECO:0000315 mutant phenotype evidence used in manual assertionchallengeC: 1
unacceptableTheresa.Hubbell,
Team Gene Autry
MOUSE:PLIN5GO:0010890 - positive regulation of sequestering of triglyceride (P)PMID:22675471ECO:0000314 direct assay evidence used in manual assertionchallengeC: 1
unacceptableKelly.huth4500,
Team Equine
HUMAN:SNAI1GO:0010629 - negative regulation of gene expression (P)PMID:23029563ECO:0000314 direct assay evidence used in manual assertionchallengeC: 1
updatedbyinstructorKelly.huth4500,
Team Equine
HUMAN:CRTC3GO:0042116 - macrophage activation (P)PMID:23033494ECO:0000315 mutant phenotype evidence used in manual assertionchallengeC: 1
updatedbyinstructorBriddle24,
Team Phatty Acidz
BPPHS:EGO:0019077 - lytic viral release (P)PMID:22742425ECO:0000315 mutant phenotype evidence used in manual assertionchallengeC: 1
updatedbyinstructorHannah smalley,
Team Gene Simmons
HHV1K:DNBIGO:0010792 - DNA double-strand break processing involved in repair via single-strand annealing (P)PMID:22912580ECO:0000315 mutant phenotype evidence used in manual assertionchallengeC: 1
updatedbyinstructorHannah smalley,
Team Gene Simmons
MOUSE:RAD52GO:0010792 - DNA double-strand break processing involved in repair via single-strand annealing (P)PMID:22912580ECO:0000315 mutant phenotype evidence used in manual assertionchallengeC: 1
acceptableHannah smalley,
Team Gene Simmons
HHV1:Q68978GO:0010792 - DNA double-strand break processing involved in repair via single-strand annealing (P)PMID:22912580ECO:0000314 direct assay evidence used in manual assertionchallengeC: 1
requireschangesVtran1,
Team Smarter Who?
HAEDU:HGBAGO:0030492 - hemoglobin binding (F)PMID:7890379ECO:0000314 direct assay evidence used in manual assertionchallengeC: 4
unacceptableAjazc,
Team Helicase
HUMAN:MCCBGO:0004485 - methylcrotonoyl-CoA carboxylase activity (C)PMID:17360195ECO:0000314 direct assay evidence used in manual assertionchallengeC: 1
updatedbyinstructorAjazc,
Team Helicase
HUMAN:MCCAGO:0004485 - methylcrotonoyl-CoA carboxylase activity (F)PMID:17360195ECO:0000314 direct assay evidence used in manual assertionchallengeC: 1
updatedbyinstructorAjazc,
Team Helicase
YEAST:PDATGO:0046027 - phospholipid:diacylglycerol acyltransferase activity (F)PMID:10829075ECO:0000266 sequence orthology evidence used in manual assertionchallengeC: 2
requireschangesVtran1,
Team Smarter Who?
HAEDU:G1UBA5GO:0009279 - cell outer membrane (C)PMID:11401984ECO:0000315 mutant phenotype evidence used in manual assertionchallengeC: 3

0 annotations fixed by Vtran1